R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Phase 1
36
about 2.7 years
18–65
4 sites in CA, FL, MN
What this study is about
This trial is testing the safety and tolerability of R-3750, an oral probiotic, in people with mild to moderate ulcerative colitis. Participants will take R-3750 orally and provide information about their condition through patient reports and doctor evaluations. Blood and stool tests will also be done to measure inflammation and assess R-3750 levels in the gut.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take R-3750
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
oral
Primary: To assess the tolerability of R-3750
Gastroenterology